Skip to main content
SpringerLink
Log in

Formulation strategy to overcome multi-drug resistance (MDR)

  • This Month in APR
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., and Gottesman, M. M., Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol., 39, 361–398 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Brigger, I., Dubernet, C., and Couvreur, P., Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev., 54, 631–651 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Chavanpatil, M. D., Khdair, A., Gerard, B., Bachmeier, C., Miller, D. W., Shekhar, M. P. V., and Panyam, J., Surfactant-polymer nanoparticles overcome P-glycoproteinmediated drug efflux. Mol. Pharm., 4, 730–738 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Cho, C. W., Kim, D. C., and Shin, S. C., Effect of ultrasoundinduced hyperthermia on cellular uptake of P-gp substrate and non-P-gp substrate in MDR cells. J. Kor. Pharm. Sci., 37,3, 131–135 (2007).

    CAS  Google Scholar 

  • Choi, J.-S., Piao, Y.-J., and Kang, K. W., Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch. Pharm. Res., 34, 607–613 (2011).

    Article  Google Scholar 

  • Chung, S. Y., Han, A. R., Sung, M. K., Jung, H. J., Nam, J. W., Seo, E. K., and Lee, H. J., Potent modulation of Pglycoprotein activity by naturally occurring phenylbutenoids from Zingiber cassumunar. Phytother. Res., 23, 472–476 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Davda, J. and Labhasetwar, V., Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm., 233, 51–59 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Dintaman, J. M. and Silverman, J. A., Inhibition of Pglycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm. Res., 16, 1550–1556 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Ferry, D. R., Traunecker, H., and Kerr, D. J., Clinical trials of P-glycoprotein reversal in solid tumours. Eur. J. Cancer, 32A, 1070–1081 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Gottesman, M. M., Fojo, T., and Bates, S. E., Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2, 48–58 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Krishna, R. and Mayer, L. D., Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci., 11, 265–283 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Li, X., Li, P., Zhang, Y., Zhou, Y., Chen, X., Huang, Y., and Liu, Y., Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously. Pharm. Res., 27, 1498–1511 (2010).

    Article  PubMed  Google Scholar 

  • Ling, V., Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol., 40Suppl, S3–S8 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Liu, Y., Huang, L., and Liu, F., Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. Mol. Pharm., 7, 863–869 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Rowinsky, E. K., Smith, L., Wang, Y. M., Chaturvedi, P., Villalona, M., Campbell, E., Aylesworth, C., Eckhardt, S. G., Hammond, L., Kraynak, M., Drengler, R., Stephenson, J. Jr., Harding, M. W., and Von Hoff, D. D., Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. J. Clin. Oncol., 16, 2964–2976 (1998).

    PubMed  CAS  Google Scholar 

  • Thomas, H. and Coley, H. M., Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control, 10, 159–165 (2003).

    PubMed  Google Scholar 

  • Werle, M., Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm. Res., 25, 500–511 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Yan, F., Zhang, C., Zheng, Y., Mei, L., Tang, L., Song, C., Sun, H., and Huang, L., The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine: Nanotechnology, Biology and Medicine, 6, 170–178 (2010).

    Article  CAS  Google Scholar 

  • Yang, T. F., Chen, C. N., Chen, M. C., Lai, C. H., Laing, H. F., and Sung, H. W., Shell-crosslinked pluronic L121 micelles as a drug delivery vehicle. Biomaterials, 28, 725–734 (2007).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon, 305-764, Korea

    Cheong-Weon Cho

Authors
  1. Cheong-Weon Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cheong-Weon Cho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, CW. Formulation strategy to overcome multi-drug resistance (MDR). Arch. Pharm. Res. 34, 511–513 (2011). https://doi.org/10.1007/s12272-011-0400-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-0400-0

Keywords

Search

Navigation